Tilray

$22.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.83 (+3.84%) As of 7:44 PM UTC today

Why Robinhood?

You can buy or sell Tilray and other stocks, options, and ETFs commission-free!

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. The listed name for TLRY is Tilray, Inc. Class 2 Common Stock.

CEO

Brendan Kennedy

Employees

1,030

Headquarters

Nanaimo, British Columbia

Founded

2018

Market Cap

4.27B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

27.78M

High Today

$23.42

Low Today

$20.80

Open Price

$21.72

Volume

13.67M

52 Week High

$67.00

52 Week Low

$2.43

TLRY News

MarketWatchMar 5

Tilray Inc. Cl 2 stock falls Friday, underperforms market

Shares of Tilray Inc. Cl 2 TLRY, -4.50% slipped 4.50% to $21.63 Friday, on what proved to be an all-around positive trading session for the stock market, with t

CNBCMar 5

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray I

Analyst Ratings

0%

of 14 ratings

Buy

Hold

93%

Sell

TLRY Earnings

-$1.45

-$0.97

-$0.48

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, After Hours